-
1
-
-
20344385026
-
Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication
-
DOI 10.1001/archpsyc.62.6.593
-
Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593-602. (Pubitemid 40973434)
-
(2005)
Archives of General Psychiatry
, vol.62
, Issue.6
, pp. 593-602
-
-
Kessler, R.C.1
Berglund, P.2
Demler, O.3
Jin, R.4
Merikangas, K.R.5
Walters, E.E.6
-
2
-
-
0032867886
-
Paroxetine in social anxiety disorder: A randomized placebo-controlled study
-
Allgulander C. Paroxetine in social anxiety disorder: a randomized placebo-controlled study. Acta Psychiatr Scand. 1999;100(3):193-198. PubMed doi:10.1/j.160-047.19.tb10845.x 3. Stein MB, Fyer AJ, Davidson JR, et al. Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study. Am J Psychiatry. 1999;156(5):756-760. (Pubitemid 29409085)
-
(1999)
Acta Psychiatrica Scandinavica
, vol.100
, Issue.3
, pp. 193-198
-
-
Allgulander, C.1
-
3
-
-
0742288274
-
The evidence-based pharmacological treatment of social anxiety disorder
-
DOI 10.1017/S1461145703003791
-
Blanco C, Raza MS, Schneier FR, et al. The evidence-based pharmacological treatment of social anxiety disorder. Int J Neuropsychopharmacol. 2003;6(4):427-442. (Pubitemid 38146264)
-
(2003)
International Journal of Neuropsychopharmacology
, vol.6
, Issue.4
, pp. 427-442
-
-
Blanco, C.1
Raza, M.S.2
Schneier, F.R.3
Liebowitz, M.R.4
-
4
-
-
0032789136
-
Treatment of social phobia with gabapentin: A placebo-controlled study
-
DOI 10.1097/00004714-199908000-00010
-
Pande AC, Davidson JR, Jefferson JW, et al. Treatment of social phobia with gabapentin: a placebo-controlled study. J Clin Psychopharmacol. 1999;19(4):341-348. (Pubitemid 29344848)
-
(1999)
Journal of Clinical Psychopharmacology
, vol.19
, Issue.4
, pp. 341-348
-
-
Pande, A.C.1
Davidson, J.R.T.2
Jefferson, J.W.3
Janney, C.A.4
Katzelnick, D.J.5
Weisler, R.H.6
Greist, J.H.7
Sutherland, S.M.8
-
5
-
-
12144285831
-
Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: A placebo-controlled multicenter study
-
Pande AC, Feltner DE, Jefferson JW, et al. Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study. J Clin Psychopharmacol. 2004;24(2):141-149.
-
(2004)
J Clin Psychopharmacol
, vol.24
, Issue.2
, pp. 141-149
-
-
Pande, A.C.1
Feltner, D.E.2
Jefferson, J.W.3
-
6
-
-
13744258074
-
An open trial of topiramate in the treatment of generalized social phobia
-
Van Ameringen M, Mancini C, Pipe B, et al. An open trial of topiramate in the treatment of generalized social phobia. J Clin Psychiatry. 2004;65(12):1674-1678.
-
(2004)
J Clin Psychiatry
, vol.65
, Issue.12
, pp. 1674-1678
-
-
Van Ameringen, M.1
Mancini, C.2
Pipe, B.3
-
7
-
-
67650107605
-
Levetiracetam for managing neurologic and psychiatric disorders
-
Farooq MU, Bhatt A, Majid A, et al. Levetiracetam for managing neurologic and psychiatric disorders. Am J Health Syst Pharm. 2009;66(6):541-561.
-
(2009)
Am J Health Syst Pharm
, vol.66
, Issue.6
, pp. 541-561
-
-
Farooq, M.U.1
Bhatt, A.2
Majid, A.3
-
8
-
-
0034864245
-
Pharmacokinetics of levetiracetam
-
Radtke RA. Pharmacokinetics of levetiracetam. Epilepsia. 2001;42 (suppl 4):24-27.
-
(2001)
Epilepsia
, vol.42
, Issue.SUPPL. 4
, pp. 24-27
-
-
Radtke, R.A.1
-
9
-
-
32544452985
-
Synaptic vesicle protein 2 enhances release probability at quiescent synapses
-
Custer KL, Austin NS, Sullivan JM, et al. Synaptic vesicle protein 2 enhances release probability at quiescent synapses. J Neurosci. 2006;26(4):1303-1313.
-
(2006)
J Neurosci
, vol.26
, Issue.4
, pp. 1303-1313
-
-
Custer, K.L.1
Austin, N.S.2
Sullivan, J.M.3
-
10
-
-
3843128847
-
High-potency benzodiazepines recent clinical results
-
Moroz G. High-potency benzodiazepines: recent clinical results. J Clin Psychiatry. 2004;65(suppl 5):13-18.
-
(2004)
J Clin Psychiatry
, vol.65
, Issue.SUPPL. 5
, pp. 13-18
-
-
Moroz, G.1
-
11
-
-
33745399645
-
Pregabalin: From molecule to medicine
-
Kavoussi R. Pregabalin: from molecule to medicine. Eur Neuropsychopharmacol. 2006;16(suppl 2):S128-S133.
-
(2006)
Eur Neuropsychopharmacol
, vol.16
, Issue.SUPPL. 2
-
-
Kavoussi, R.1
-
12
-
-
34548315740
-
Levetiracetam as adjunctive therapy for refractory anxiety disorders
-
Kinrys G, Worthington JJ, Wygant L, et al. Levetiracetam as adjunctive therapy for refractory anxiety disorders. J Clin Psychiatry. 2007;68(7):1010-1013. (Pubitemid 47340319)
-
(2007)
Journal of Clinical Psychiatry
, vol.68
, Issue.7
, pp. 1010-1013
-
-
Kinrys, G.1
Worthington, J.J.2
Wygant, L.3
Nery, F.4
Reese, H.5
Pollack, M.H.6
-
13
-
-
33644822479
-
Levetiracetam for treatment-refractory posttraumatic stress disorder
-
Kinrys G, Wygant LE, Pardo TB, et al. Levetiracetam for treatment-refractory posttraumatic stress disorder. J Clin Psychiatry. 2006;67(2):211-214. (Pubitemid 43357466)
-
(2006)
Journal of Clinical Psychiatry
, vol.67
, Issue.2
, pp. 211-214
-
-
Kinrys, G.1
Wygant, L.E.2
Pardo, T.B.3
Melo, M.4
-
14
-
-
33751237676
-
Safety and efficacy of levetiracetam for patients with panic disorder: Results of an open-label fixed-flexible dose study
-
Papp LA. Safety and efficacy of levetiracetam for patients with panic disorder: results of an open-label, fixed-flexible dose study. J Clin Psychiatry. 2006;67(10):1573-1576.
-
(2006)
J Clin Psychiatry
, vol.67
, Issue.10
, pp. 1573-1576
-
-
Papp, L.A.1
-
15
-
-
5444235771
-
An open-label study of levetiracetam for the treatment of social anxiety disorder
-
Simon NM, Worthington JJ, Doyle AC, et al. An open-label study of levetiracetam for the treatment of social anxiety disorder. J Clin Psychiatry. 2004;65(9):1219-1222.
-
(2004)
J Clin Psychiatry
, vol.65
, Issue.9
, pp. 1219-1222
-
-
Simon, N.M.1
Worthington, J.J.2
Doyle, A.C.3
-
16
-
-
25844473118
-
Levetiracetam in social phobia: A placebo controlled pilot study
-
DOI 10.1177/0269881105056526
-
Zhang W, Connor KM, Davidson JR. Levetiracetam in social phobia: a placebo controlled pilot study. J Psychopharmacol. 2005;19(5): 551-553. (Pubitemid 41392309)
-
(2005)
Journal of Psychopharmacology
, vol.19
, Issue.5
, pp. 551-553
-
-
Zhang, W.1
Connor, K.M.2
Davidson, J.R.T.3
-
17
-
-
0032421570
-
The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10
-
Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33. (Pubitemid 29001829)
-
(1998)
Journal of Clinical Psychiatry
, vol.59
, Issue.SUPPL. 20
, pp. 22-33
-
-
Sheehan, D.V.1
Lecrubier, Y.2
Sheehan, K.H.3
Amorim, P.4
Janavs, J.5
Weiller, E.6
Hergueta, T.7
Baker, R.8
Dunbar, G.C.9
-
18
-
-
0032956810
-
Psychometric properties of the Liebowitz Social Anxiety Scale
-
DOI 10.1017/S0033291798007879
-
Heimberg RG, Horner KJ, Juster HR, et al. Psychometric properties of the Liebowitz Social Anxiety Scale. Psychol Med. 1999;29(1):199-212. (Pubitemid 29034537)
-
(1999)
Psychological Medicine
, vol.29
, Issue.1
, pp. 199-212
-
-
Heimberg, R.G.1
Horner, K.J.2
Juster, H.R.3
Safren, S.A.4
Brown, E.J.5
Schneier, F.R.6
Liebowitz, M.R.7
-
20
-
-
0003412410
-
-
US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, MD: National Institute of Mental Health
-
Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, MD: National Institute of Mental Health;1976:218-222.
-
(1976)
ECDEU Assessment Manual for Psychopharmacology
, pp. 218-222
-
-
Guy, W.1
|